Vol. 41 | No. 1 | January-June 2013Back

Open Access

Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension (PRESYON 3): A Report on Prevalence of Hypertension, Awareness and Treatment Profile

More Info

Philippine Heart Association-Council on Hypertension* 

For correspondence: Jorge A. Sison, MD; Council on Hypertension, Philippine Heart Association 

E-mail: phil.heart@yahoo.com

 

  1. Sison J, et al. National Registry Program for the Prevalence of Hypertension in the Philippines – A Report of the Council on Hypertension. ASEAN Heart Journal 1993;2:29-31. 
  2. Sison J, et al. Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension (PRESYON 1). Phil J Cardiol 1998;26:51-54. 
  3. Sison J, et al. Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension (PRESYON-2). Phil J Cardiol 2007.35:1-9. 
  4. Morales D, et al. 6th National Nutrition and Health Survey (NNHeS). Phil J Cardiol 2005; 33. 
  5. Morales D, et al. 7th National Nutrition and Health Survey (NNHeS). 17th Joint Annual Convention, PSH-PLAS 2008. 
  6. Sison J, et al. Philippine Hypertension and Target Organ Survey (PHYTON 1) – A Report of the Council on Hypertension. Phil J of Cardiol 1996; 24:39-44. 
  7. Atabug J, et al. Detection and Management of Microproteinuria, A Parameter of Early Kidney Damage in Hypertension (PHYTON 2). Phil J of Cardiol 1997;25:172-177. 
  8. Atabug J, et al. Survey of Clinical Profile of Hypertensive Filipinos with Stroke (PHYTON 3). Phil J of Cardiol July-Sept. 1999;27:134- 137. 
  9. Sison J, et al. A Nationwide Survey on Morbidity and Mortality Among Hospital-Based Population in the Philippines (PHYTON 4), A Report of the Council on Hypertension – Philippine Heart Association. Phil J Cardiol 2005; 33. 
  10. Chobanian Aram etal. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206. 

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.